• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor.一名接受IL-17抑制剂治疗的银屑病关节炎患者感染了新型冠状病毒。
Med Hypotheses. 2020 Nov;144:110040. doi: 10.1016/j.mehy.2020.110040. Epub 2020 Jul 1.
2
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
3
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.德国炎症性风湿病（IRD）患者感染 SARS-CoV-2 的国家登记处（ReCoVery）：了解 IRD 患者 SARS-CoV-2 感染临床病程的快速可靠知识的宝贵手段。
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001332.
4
Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.在新冠疫情期间阿普米司特在银屑病关节炎患者中的应用：对米库尔斯等人文章的评论
Arthritis Rheumatol. 2021 Mar;73(3):547-548. doi: 10.1002/art.41575. Epub 2021 Jan 29.
5
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".回复：“2019冠状病毒病、梅毒与银屑病和银屑病关节炎的生物疗法：一则警示”
J Am Acad Dermatol. 2020 Jun;82(6):e215. doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.
6
COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.新型冠状病毒肺炎、梅毒与银屑病及银屑病关节炎的生物治疗：一则警示
J Am Acad Dermatol. 2020 Jun;82(6):e213. doi: 10.1016/j.jaad.2020.03.079. Epub 2020 Apr 1.
7
Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation.银屑病患者在新冠疫情期间的担忧与认知：美国国家银屑病基金会两阶段调查结果
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e354-e355. doi: 10.1111/jdv.17173. Epub 2021 Mar 2.
8
Biologics, spondylitis and COVID-19.生物制剂、脊柱炎与新型冠状病毒肺炎
Ann Rheum Dis. 2020 Dec;79(12):1663-1665. doi: 10.1136/annrheumdis-2020-217941. Epub 2020 Jun 10.
9
REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.回复：白细胞介素-17：新冠病毒病的一个潜在治疗靶点。
J Infect. 2020 Sep;81(3):e37-e38. doi: 10.1016/j.jinf.2020.06.063. Epub 2020 Jun 29.
10
Biologics in systemic autoimmune diseases during COVID-19 pandemic.新冠疫情期间系统性自身免疫性疾病中的生物制剂
Clin Rheumatol. 2020 Dec;39(12):3529-3531. doi: 10.1007/s10067-020-05439-z. Epub 2020 Oct 4.

引用本文的文献

1
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.银屑病、银屑病关节炎和中轴型脊柱关节炎患者 COVID-19 结局不良的相关特征：COVID-19 PsoProtect 和全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2023 May;82(5):698-709. doi: 10.1136/ard-2022-223499. Epub 2023 Feb 14.
2
Biologics for Psoriasis During the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
Front Med (Lausanne). 2021 Dec 6;8:759568. doi: 10.3389/fmed.2021.759568. eCollection 2021.
3
Biologics for Psoriasis during the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
J Clin Med. 2021 Mar 30;10(7):1390. doi: 10.3390/jcm10071390.

本文引用的文献

1
SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.一名接受白细胞介素-17抑制剂治疗的银屑病患者感染了新型冠状病毒。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e357-e358. doi: 10.1111/jdv.16571. Epub 2020 Jun 8.
2
May IL-17 have a role in COVID-19 infection?白细胞介素-17在新型冠状病毒肺炎感染中起作用吗？
Med Hypotheses. 2020 Jul;140:109749. doi: 10.1016/j.mehy.2020.109749. Epub 2020 Apr 22.
3
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
4
Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.白细胞介素-6（IL-6）和白细胞介素-17 通过抑制细胞凋亡和细胞毒性 T 细胞功能协同促进病毒持续存在。
J Virol. 2014 Aug;88(15):8479-89. doi: 10.1128/JVI.00724-14. Epub 2014 May 14.

SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor.

作者信息

Foti Rosario, Amato Giorgio, Visalli Elisa

机构信息

Rheumatology Unit AOU Policlinico Vittorio Emanuele Catania.

Rheumatology Unit AOU Policlinico Vittorio Emanuele Catania.

出版信息

Med Hypotheses. 2020 Nov;144:110040. doi: 10.1016/j.mehy.2020.110040. Epub 2020 Jul 1.

DOI:10.1016/j.mehy.2020.110040
PMID:32744241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7328605/
Abstract
摘要